363 related articles for article (PubMed ID: 19438449)
1. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
2. Primary invasive carcinoma associated with penoscrotal extramammary Paget's disease: a clinicopathological analysis of 56 cases.
Dai B; Kong YY; Chang K; Qu YY; Ye DW; Zhang SL; Zhang HL
BJU Int; 2015 Jan; 115(1):153-60. PubMed ID: 24731175
[TBL] [Abstract][Full Text] [Related]
3. Primary invasive extramammary Paget disease on penoscrotum: a clinicopathological analysis of 41 cases.
Shu B; Shen XX; Chen P; Fang XZ; Guo YL; Kong YY
Hum Pathol; 2016 Jan; 47(1):70-7. PubMed ID: 26508372
[TBL] [Abstract][Full Text] [Related]
4. Frozen section-guided wide local excision in the treatment of penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Chen ZW; Zhang SL; Qin XJ
BJU Int; 2007 Dec; 100(6):1282-7. PubMed ID: 17850363
[TBL] [Abstract][Full Text] [Related]
5. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Hirai I; Funakoshi T
J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget's disease: a study of 31 patients.
Choi YD; Cho NH; Park YS; Cho SH; Lee G; Park K
J Urol; 2005 Aug; 174(2):561-5. PubMed ID: 16006892
[TBL] [Abstract][Full Text] [Related]
7. [Observations on signet cell invasion and metastasis in extra-mammary Paget's disease].
Xu H; Li N; Li W
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):294-5. PubMed ID: 9388876
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic significance of Stat5a and E-cadherin in extramammary Paget's disease.
Liu H; Urabe K; Uchi H; Takeuchi S; Nakahara T; Dainichi T; Tu Y; Furue M; Moroi Y
J Cutan Pathol; 2007 Jan; 34(1):33-8. PubMed ID: 17214852
[TBL] [Abstract][Full Text] [Related]
9. Trial of low-dose 5-fluorouracil/cisplatin therapy for advanced extramammary Paget's disease.
Kariya K; Tsuji T; Schwartz RA
Dermatol Surg; 2004 Feb; 30(2 Pt 2):341-4. PubMed ID: 14871231
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of extramammary Paget's disease: report of 246 Chinese male patients.
Kang Z; Zhang Q; Zhang Q; Li X; Hu T; Xu X; Wu Z; Zhang X; Wang H; Xu J; Xu F; Guan M
Int J Clin Exp Pathol; 2015; 8(10):13233-40. PubMed ID: 26722523
[TBL] [Abstract][Full Text] [Related]
11. Extramammary Paget's disease: treatment, prognostic factors and outcome in 76 patients.
Hatta N; Yamada M; Hirano T; Fujimoto A; Morita R
Br J Dermatol; 2008 Feb; 158(2):313-8. PubMed ID: 18028492
[TBL] [Abstract][Full Text] [Related]
12. Metastatic extramammary Paget's disease treated with paclitaxel and trastuzumab combination chemotherapy.
Takahagi S; Noda H; Kamegashira A; Madokoro N; Hori I; Shindo H; Mihara S; Hide M
J Dermatol; 2009 Aug; 36(8):457-61. PubMed ID: 19691751
[TBL] [Abstract][Full Text] [Related]
13. Prognostic indicators in 35 patients with extramammary Paget's disease.
Ito Y; Igawa S; Ohishi Y; Uehara J; Yamamoto AI; Iizuka H
Dermatol Surg; 2012 Dec; 38(12):1938-44. PubMed ID: 22989161
[TBL] [Abstract][Full Text] [Related]
14. High expression of Ki-67 and cyclin D1 in invasive extramammary Paget's disease.
Aoyagi S; Akiyama M; Shimizu H
J Dermatol Sci; 2008 Jun; 50(3):177-84. PubMed ID: 18248961
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of extramammary Paget's disease of the scrotum associated with sweat gland adenocarcinoma-a clinical retrospective study.
Yan D; Dai H; Jin M; Zhao Y
J Chin Med Assoc; 2011 Apr; 74(4):179-82. PubMed ID: 21463849
[TBL] [Abstract][Full Text] [Related]
16. MUC5AC expression correlates with invasiveness and progression of extramammary Paget's disease.
Hata H; Abe R; Hoshina D; Saito N; Homma E; Aoyagi S; Shimizu H
J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):727-32. PubMed ID: 23581859
[TBL] [Abstract][Full Text] [Related]
17. Treatment outcomes in a large cohort of patients with invasive Extramammary Paget's disease.
Karam A; Dorigo O
Gynecol Oncol; 2012 May; 125(2):346-51. PubMed ID: 22293043
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
Yoshino K; Fujisawa Y; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Ohara K
J Dermatol; 2016 Jun; 43(6):633-7. PubMed ID: 26603144
[TBL] [Abstract][Full Text] [Related]
19. Brain metastasis from extramammary Paget's disease of the scrotum.
Kim IY; Yun SJ; Lee JS; Jung S; Jung TY; Moon KS; Jang WY
J Clin Neurosci; 2014 Apr; 21(4):694-6. PubMed ID: 24210806
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin expression in peritumoral keratinocytes predicts aggressive behavior in extramammary Paget's disease.
Cho Z; Konishi E; Kanemaru M; Isohisa T; Arita T; Kawai M; Tsutsumi M; Mizutani H; Takenaka H; Ozawa T; Tsuruta D; Katoh N; Asai J
J Dermatol Sci; 2017 Jul; 87(1):29-35. PubMed ID: 28381343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
